3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Sarcoma
11
Osteosarcoma
4
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Oligodendroglioma
2
Meningioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Hemangiosarcoma
2
Gliosarcoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Brain Neoplasms
2
Bone Neoplasms
2
Astrocytoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Radiation Injuries
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Plexosarcoma
1
Pituitary Neoplasms
1
Interventions
Ifosfamide
5
Filgrastim
5
Doxorubicin
5
Gemcitabine
4
Docetaxel
4
Radiotherapy
3
Proton Therapy
3
Carboplatin
3
regorafenib
2
ivosidenib
2
enasidenib
2
belinostat
2
Sunitinib
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immune Checkpoint Inhibitors
2
HhAntag691
2
Fluorouracil
2
Etoposide
2
Epirubicin
2
Cyclophosphamide
2
Cisplatin
2
Chemotherapy, Adjuvant
2
Celecoxib
2
Bevacizumab
2
venetoclax
1
toripalimab
1
temsirolimus
1
tazemetostat
1
tanespimycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
Surveys and Questionnaires
×
Sarcoma
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled